BioRem Inc.

BIRMF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$3,044$2,179$1,613$1,297
Dep. & Amort.$473$383$351$344
Deferred Tax$383$459$84$382
Stock-Based Comp.$143$128$94$8
Change in WC-$441-$2,742-$736$1,700
Other Non-Cash$83$84$40$51
Operating Cash Flow$3,685$490$1,445$3,782
Investing Activities
PP&E Inv.-$372-$553-$203-$76
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$372-$553-$203-$76
Financing Activities
Debt Repay.-$729-$623-$954$3,761
Stock Issued$157$69$2$0
Stock Repurch.$0$0$0-$12,411
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$775$0$1,095
Financing Cash Flow-$572-$1,329-$952-$7,556
Forex Effect$180-$91-$986-$548
Net Chg. in Cash$2,921-$1,483-$696-$4,398
Supplemental Information
Beg. Cash$2,292$3,775$4,471$8,869
End Cash$5,213$2,292$3,775$4,471
Free Cash Flow$3,313-$63$1,242$3,706
BioRem Inc. (BIRMF) Financial Statements & Key Stats | AlphaPilot